| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.82 | 0.001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.03 |